2020 annual financial data
Voyager Therapeutics 2020 Operating margin
Direct answer
Operating margin was 16%.
Operating income was 27,384,000 USD and net income was 36,741,000 USD.
Operating cash flow was -96,716,000 USD.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 171,128,000 USD
- Operating income
- 27,384,000 USD
- Net income
- 36,741,000 USD
- Operating cash flow
- -96,716,000 USD